Clinical data from investigational study of patients with multiple myeloma presented at ASCO

Links shared publicly online about this topic.

1,101
total visits

Clinical data from investigational study of patients with multiple myeloma presented at ASCO

Celgene International Sàrl announced clinical data from an investigational study of patients with multiple myeloma who were younger than 65 years old and received either lenalidomide (REVLIMID), melphalan and prednisone or melphalan plus autologous stem cell transplant (MEL200) following an induction treatment of lenalidomide plus low-dose dexamethasone (Rd) were presented at the American Society of Clinical Oncology annual meeting.

View full resource at news-medical.net

Tags: Ulcerative Colitis Medication, Multiple Myeloma, Stem Cell, Pregnancy, Decadron, Dexamethasone Intensol, Prednisone, Transplantation